Clorox maintained flat sales year-over-year and slightly improved its earnings per share despite facing pressure from rising energy costs that squeezed gross margins. Using a dividend discount model with assumptions of 2% perpetual growth and a 7.7% required return, the stock shows limited potential for price appreciation. Due to these factors, the analyst upgraded Clorox stock to a hold rating, indicating cautious optimism but no strong buy signal at current prices.
Clorox's CEO Linda Rendle stepped down for health reasons, causing a 6% drop in shares amid succession uncertainty. This event underscores the hidden risks investors face, such as leadership changes, customer concentration, refinancing, currency fluc...
This monthly series highlights five large-cap, dividend-paying stocks trading at significant discounts compared to their historical norms, selected from over 7,500 U.S.-listed companies. The primary list offers an average yield of 4.2%, with two addi...
Clorox Healthcare introduced two new disinfecting wipes: Quat Alcohol Disinfecting Wipes with 40% less alcohol and a 1-minute contact time, and HyperOxi Disinfecting Wipes, a bleach-free sporicidal wipe using Quanticare Technology. These products add...
